Pfm Health Sciences, LP Novavax Inc Transaction History

Pfm Health Sciences, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $6.18 Million - $12.7 Million	-88,663 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $14.6 Million - $23.7 Million	-108,545 Reduced 55.04%	88,663 $12.7 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $8.55 Million - $13 Million	48,104 Added 32.26%	197,208 $40.9 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $6.25 Million - $13.3 Million	-51,641 Reduced 25.72%	149,104 $31.7 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $1.71 Million - $4.85 Million	-15,163 Reduced 7.02%	200,745 $36.4 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $17 Million - $30.1 Million	215,908 New	215,908 $24.1 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.